Fresenius Medical Care | FME - Ordinary Share Capital


Fresenius Medical Care reported EUR270.09M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Akzo Nobel EUR 171.41M 100K Jun/2026
Alcon AG USD 487.4M 0 Mar/2026
AstraZeneca USD 1.55B 44K Jun/2026
Bayer EUR 982.42M 0 Dec/2025
Beiersdorf EUR 218.92M 1.29M Dec/2025
DaVita Healthcare Partners USD 66.18M 2.36M Mar/2026
Demant DKK 210.9M 5.18M Dec/2025
E.ON EUR 2.61B 0 Mar/2026
Essilor EUR 463.19M 144.06K Jun/2026
Fresenius EUR 563.24M 0 Dec/2025
Fresenius Medical Care EUR 270.09M 9.2M Mar/2026
Genmab DKK 61.62M 52K Dec/2025
Getinge SEK 272.37M 136.37M Jun/2026
Givaudan CHF 9.23M 0 Dec/2025
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
GN Store Nord DKK 145.61M 0 Mar/2026
GRIFOLS EUR 680.58M 6K Jun/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Mar/2026
Novartis USD 1.9B 7.38M Jun/2026
Philips EUR 952.02M 729K Mar/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
RWE EUR 713.56M 0 Mar/2026
Sanofi EUR 1.21B 8.25M Mar/2026
SAP EUR 1.17B 1.06M Mar/2026
Smith & Nephew USD 875.96M 1.61M Dec/2025